BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18044711)

  • 21. Critical increment of Lewis blood group antigen in serum by cancer found by photothermal immunoassay.
    Kimura H; Kitamori T; Sawada T
    Anal Biochem; 1999 Oct; 274(1):98-103. PubMed ID: 10527501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers].
    Kawakita M; Hiramatsu K; Sugimoto M; Takahashi K; Toi M
    Rinsho Byori; 2004 Apr; 52(4):321-7. PubMed ID: 15164599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker].
    Kawakita M; Hiramatsu K; Takahashi K; Yamada R; Kawaguchi M; Shinoura N; Tanaka T; Kariyone K; Tamamori Y; Sasaki Y; Mori T
    Rinsho Byori; 2005 Feb; 53(2):123-9. PubMed ID: 15796045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
    Desmetz C; Bibeau F; Boissière F; Bellet V; Rouanet P; Maudelonde T; Mangé A; Solassol J
    J Proteome Res; 2008 Sep; 7(9):3830-7. PubMed ID: 18683965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-dimensional electrophoretic analysis of nuclear matrix proteins in human colon adenocarcinoma.
    Toumpanaki A; Baltatzis GE; Gaitanarou E; Seretis E; Toumpanakis C; Aroni K; Kittas C; Voloudakis-Baltatzis IE
    Ultrastruct Pathol; 2009; 33(2):83-91. PubMed ID: 19274585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Gervasoni A; Monasterio Muñoz RM; Wengler GS; Rizzi A; Zaniboni A; Parolini O
    Cancer Lett; 2008 May; 263(2):267-79. PubMed ID: 18262345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer.
    Müller H; Haug U; Rothenbacher D; Stegmaier C; Brenner H
    J Urol; 2008 Oct; 180(4):1309-12; discussion 1312-3. PubMed ID: 18707695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid and simple detection of a mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA.
    El-Masry S; El-Kady I; Zaghloul MH; Al-Badrawey MK
    Clin Biochem; 2008 Feb; 41(3):145-51. PubMed ID: 18082139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
    Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
    Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.
    Japink D; Leers MP; Sosef MN; Nap M
    Anticancer Res; 2009 Aug; 29(8):3245-51. PubMed ID: 19661342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker CCSA-2 may provide accurate blood test for colorectal cancer.
    Oncology (Williston Park); 2008 Feb; 22(2):147. PubMed ID: 18409660
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fecal oncomarkers in the diagnostics of colorectal cancer].
    Mikhaĭlova EI; Pimanov SI; Voropaev EV
    Klin Med (Mosk); 2007; 85(12):62-7. PubMed ID: 18318171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.